On September 10 2025, the BioMed Alliance submitted its response to the European Commission’s call for evidence for an impact assessment on the upcoming European Research Era (ERA) Act. While welcoming the Commission’s ambition to strengthen research across Europe, we emphasize that the new Act must be fit for purpose and avoid adding unnecessary regulatory complexity.
You can find the full response on the European Commission’s feedback platform: Feedback from: BioMed Alliance
